PharmaCyte Biotech(DE:EFYA)
€2.520.00 (0.00%)
DE:EFYA
PharmaCyte Biotech financials statements
€2.52
At close:0.00 (0.00%)
PharmaCyte Biotech (EFYA) Income Statement
2 Followers
PharmaCyte Biotech Income Statement
Last quarter (Q1 2027), PharmaCyte Biotech's total revenue was $0.00. In Q1, PharmaCyte Biotech's net income was $-5.08M. See PharmaCyte Biotech’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Apr 26 | Apr 25 | Apr 24 | Apr 23 | Apr 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 6.85M | $ 4.38M | $ 8.52M | $ 6.46M | $ 4.39M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| $ -5.30M | $ -4.38M | $ -6.52M | $ -6.46M | $ -4.24M | |
| $ -6.85M | $ -4.38M | $ -8.52M | $ -6.46M | $ -4.39M | |
| $ -12.57M | $ 35.03M | $ 8.85M | $ 2.14M | $ 152.85K | |
| $ -19.42M | $ 30.66M | $ 333.76K | $ -4.32M | $ -4.24M | |
| $ -19.42M | $ 30.66M | $ 333.76K | $ -4.32M | $ -4.24M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.77 | $ 3.19 | $ -1.80 | $ -0.22 | $ -0.27 |
| Diluted EPS | $ -2.77 | $ 3.19 | $ -1.80 | $ -0.22 | $ -0.27 |
| Weighted Average Shares Outstanding | 7.01M | 7.33M | 185.00K | 19.49M | 15.52M |
| Weighted Average Shares Outstanding (Diluted) | 8.38M | 7.33M | 9.58M | 19.49M | 15.52M |
Currency in USD
